New triple therapy shows promise for aggressive lung cancer
Disease control
Ongoing
This study tested a new treatment for people with extensive-stage small cell lung cancer, a fast-growing type of lung cancer that has spread. The treatment combined low-dose radiation, an immunotherapy drug (durvalumab), and standard chemotherapy. The goal was to see if this comb…
Phase: PHASE2 • Sponsor: You Lu • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC